That was my guess too. We knew that the bashers would show up here. They know better than to be too rabid, so the soft bashing approach is their current method.

In case people didn't read my previous posts, I say again, leedom is a basher. If you reply, please bear that in mind rather than trying to explain things to someone who claims to own over 300k shares but seems oddly "ignorant" about the stock.

By the way, speaking of said fake ignorance, we've known for a long time from company press releases that otitis (ear infections) would be a potential target for Brilacidin -- just to address an earlier post.